Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 16:10:486.
doi: 10.1186/1471-2458-10-486.

Examining appropriate diagnosis and treatment of malaria: availability and use of rapid diagnostic tests and artemisinin-based combination therapy in public and private health facilities in south east Nigeria

Affiliations

Examining appropriate diagnosis and treatment of malaria: availability and use of rapid diagnostic tests and artemisinin-based combination therapy in public and private health facilities in south east Nigeria

Benjamin S C Uzochukwu et al. BMC Public Health. .

Abstract

Background: Rapid diagnostic tests (RDTs) and Artemisinin-based combination therapy (ACT) have been widely advocated by government and the international community as cost-effective tools for diagnosis and treatment of malaria. ACTs are now the first line treatment drug for malaria in Nigeria and RDTs have been introduced by the government to bridge the existing gaps in proper diagnosis. However, it is not known how readily available these RDTs and ACTs are in public and private health facilities and whether health workers are actually using them. Hence, this study investigated the levels of availability and use of RDTs and ACTs in these facilities.

Methods: The study was undertaken in Enugu state, southeast Nigeria in March 2009. Data was collected from heads of 74 public and private health facilities on the availability and use of RDTs and ACTs. Also, the availability of RDTs and the types of ACTs that were available in the facilities were documented.

Results: Only 31.1% of the health facilities used RDTs to diagnose malaria. The majority used the syndromic approach. However, 61.1% of healthcare providers were aware of RDTs. RDTs were available in 53.3% of the facilities. Public health facilities and health facilities in the urban areas were using RDTs more and these were mainly bought from pharmacy shops and supplied by NGOs. The main reasons given for non use are unreliability of RDTs, supply issues, costs, preference for other methods of diagnosis and providers' ignorance. ACTs were the drug of choice for most public health facilities and the drugs were readily available in these facilities.

Conclusion: Although many providers were knowledgeable about RDTs, not many facilities used it. ACTS were readily available and used in public but not private health facilities. However, the reported use of ACTs with limited proper diagnosis implies that there could be high incidence of inappropriate case management of malaria which can also increase the economic burden of illnesses. Government and donors should ensure constant availability of RDTs in both public and private facilities, so that every treatment with ACTs is accompanied with proper diagnosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of the sampling method.

Similar articles

Cited by

References

    1. World Health Organization. The Africa Malaria Report 2006. World Health Organization, Geneva; 2006.
    1. Federal Ministry of Health (FMOH) Report of the malaria situation analysis survey conducted in the six zones of Nigeria. FMOH, Abuja, Nigeria; 2000.
    1. Federal Ministry of Health (FMOH) National Antimalarial Treatment Guidelines. National Malaria and Vector Control Division Abuja, Nigeria; 2005.
    1. World Health Organization. World Malaria Report 2008. World Health Organization, Geneva; 2008.
    1. Jimoh A, Sofola O, Petu A, Okorosobo T. Quantifying the Economic Burden of Malaria in Nigeria Using the Willingness to Pay Approach. Cost Effectiveness and Resource Allocation. 2007;5:6. doi: 10.1186/1478-7547-5-6. - DOI - PMC - PubMed

MeSH terms